Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1979 Sep;16(3):177-81.
doi: 10.1007/BF00562058.

Prazosin, pharmacokinetics and concentration effect

Prazosin, pharmacokinetics and concentration effect

D N Bateman et al. Eur J Clin Pharmacol. 1979 Sep.

Abstract

The pharmacokinetics and effects of prazosin have been studied after intravenous and oral dosing (1 mg) to 6 normal male volunteers. The mean terminal (beta) half-life was 2.9 h after intravenous and oral routes. Oral bioavailability was 56.9%. The effects of prazosin on blood pressure were more pronounced after intravenous than oral administration, and the hypotensive effect greater on erect blood pressure. There was a significant correlation (P less than 0.02) between the fall in blood pressure and the plasma drug concentration after intravenous prazosin.

PubMed Disclaimer

Similar articles

  • Prazosin kinetics in essential hypertension.
    Chau NP, Flouvat BL, Le Roux E, Safar ME. Chau NP, et al. Clin Pharmacol Ther. 1980 Jul;28(1):6-11. doi: 10.1038/clpt.1980.123. Clin Pharmacol Ther. 1980. PMID: 7389255
  • Dose-dependent bioavailability of prazosin in beagle dogs.
    Baughman RA Jr, Sorgel F, Mico BA, Benet LZ. Baughman RA Jr, et al. J Cardiovasc Pharmacol. 1983 Jul-Aug;5(4):613-7. doi: 10.1097/00005344-198307000-00016. J Cardiovasc Pharmacol. 1983. PMID: 6193359
  • Clinical pharmacokinetics of prazosin.
    Jaillon P. Jaillon P. Clin Pharmacokinet. 1980 Jul-Aug;5(4):365-76. doi: 10.2165/00003088-198005040-00004. Clin Pharmacokinet. 1980. PMID: 6994981 Review.
  • Prazosin kinetics in hypertension.
    Grahnén A, Seideman P, Lindström B, Haglund K, von Bahr C. Grahnén A, et al. Clin Pharmacol Ther. 1981 Oct;30(4):439-46. doi: 10.1038/clpt.1981.186. Clin Pharmacol Ther. 1981. PMID: 7285477
  • Clinical pharmacokinetics of prazosin--1985.
    Vincent J, Meredith PA, Reid JL, Elliott HL, Rubin PC. Vincent J, et al. Clin Pharmacokinet. 1985 Mar-Apr;10(2):144-54. doi: 10.2165/00003088-198510020-00002. Clin Pharmacokinet. 1985. PMID: 3888489 Review.

Cited by

References

    1. Br Med J. 1976 Nov 27;2(6047):1293-4 - PubMed
    1. N Engl J Med. 1977 Aug 11;297(6):303-7 - PubMed
    1. Xenobiotica. 1977 Jun;7(6):357-64 - PubMed
    1. Drugs. 1977 Sep;14(3):163-97 - PubMed
    1. J Clin Pharmacol. 1978 Aug-Sep;18(8-9):402-6 - PubMed

LinkOut - more resources